Table 1.
Clinical characteristics of study population
| Variables | Low‐ SIRI | High‐ SIRI | p Value |
|---|---|---|---|
| (N = 95) | (N = 52) | ||
| Median age (years) | 48.92 ± 14.62 | 54.71 ± 13.44 | .019 |
| Male (N, %) | 62 (65.3%) | 40 (76.9%) | .144 |
| WBC (×109/L) | 7.73 ± 2.52 | 13.42 ± 5.99 | <.001 |
| Lym (×109/L) | 1.47 ± 0.70 | 1.08 ± 0.50 | <.001 |
| Mo (×109/L) | 0.45 ± 0.19 | 0.80 ± 0.45 | <.001 |
| Neu (×109/L) | 5.67 ± 2.04 | 11.43 ± 5.66 | <.001 |
| HB (g/L) | 106.94 ± 20.63 | 104.54 ± 18.63 | .487 |
| PLT (×109/L) | 210.18 ± 119.96 | 176.85 ± 88.10 | .081 |
| ALT (U/L) | 22.7 (6.1−280.20) | 24.8 (3.00−2433.30) | .556 |
| AST (U/L) | 23.3 (10.3−218.60) | 27.5 (9.10−3654.20) | .146 |
| UREA (mmol/L) | 6.01 ± 4.14 | 8.64 ± 5.56 | .001 |
| CREA (mmol/L) | 67.3 (37.10−944.20) | 81.7 (47.10−902.00) | <.001 |
| NLR | 3.95 (1.01−17.15) | 9.33 (4.50−72.53) | <.001 |
| PLR | 162.32 ± 88.42 | 195.34 ± 141.86 | .087 |
| LWR | 19.44 ± 7.90 | 8.83 ± 3.84 | <.001 |
| SII | 749.02 (141.79−4398.06) | 1614.67 (312.88−10009.6) | <.001 |
| Mortality (%) | 4.21 | 30.8 | <.001 |
| Surgery (%) | 84.2 | 59.6 | .001 |
Abbrebiations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CREA, creatinine; HB, hemoglobin; Lym, lymphocyte; LWR = Lym/WBC; Mo, monocyte; Neu, neutrophil; NLR = Neu/Lym; PL, platelet; PLR = PLT/Lym; SII = PLT × Neu/Lym; UREA, urea nitrogen; WBC, white blood cell.